会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 27. 发明申请
    • MONITORING CIRCADIAN ACTIVITY
    • 监测CIRCADIAN活动
    • WO2004091382A3
    • 2006-07-20
    • PCT/US2004009699
    • 2004-03-31
    • CARNEGIE INST OF WASHINGTONBORJIGIN JIMO
    • BORJIGIN JIMO
    • C07D209/16A61B20060101A61B5/00A61B17/16A61K49/00
    • G01N33/9406A61B5/415A61B5/4857G01N33/5058G01N33/5088G01N33/942G01N2800/2864
    • The invention is directed to a new method for long-term measurement of daily serotonin (5-­HT) and melatonin contents in the pineal gland. The disclosed method allows visualization of the pineal gland for accurate targeting of the guide cannula which minimizes bleeding, incurs no direct injury to the surrounding brain tissue and cause no interference with the sympathetic innervation from the superior cervical ganglion. The improved method allows effects of pharmacological agents on in vivo pineal gland circulation to be studied reproducibly over time and gene expression profiles correlated with physiological consequences in the same or different individuals. More importantly, the method allows accurate assessment of the endogenous circadian clock function. The method can be used for high throughput screening to identify candidate agents which may accelerate adaptation to new time zones, to alleviate symptoms resulting from jet lag, frequent shift work sleep abnormalities and seasonal affective illnesses.
    • 本发明涉及一种用于长期测量松果体中日常5-羟色胺(5-HT)和褪黑激素含量的新方法。 所公开的方法允许松果体的可视化以精确地定向引导套管,从而使出血最小化,不会对周围脑组织造成直接的伤害,并且不会妨碍来自上颈椎神经节的交感神经支配。 改进的方法允许药物剂对体内松果体循环的影响随着时间的推移可重复研究,基因表达谱与相同或不同个体的生理后果相关。 更重要的是,该方法可以准确评估内源昼夜节律钟功能。 该方法可用于高通量筛选以鉴定可加速适应新时区的候选药物,以减轻由于时差,频繁换班工作睡眠异常和季节性情感疾病引起的症状。
    • 28. 发明申请
    • CANDIDATE GENES, PATHWAYS AND MECHANISMS FOR BIPOLAR AND RELATED DISORDERS
    • 候鸟基因,途径和机制用于双极和相关疾病
    • WO2005034719A3
    • 2006-07-13
    • PCT/US2004015261
    • 2004-05-17
    • UNIV CALIFORNIANICULESCU ALEXANDER BKUCZENSKI RONALD TLOHR JAMES B
    • NICULESCU ALEXANDER BKUCZENSKI RONALD TLOHR JAMES B
    • C12Q1/68A61B20060101C07H21/04
    • C12Q1/6883B82Y15/00B82Y30/00C12Q2600/158
    • Identification of nucleic acids and gene expression profiles involved in neuropsychiatric disorders (e.g., bipolar and related disorders), and the use of such expression profiles and nucleic acids in methods for identifying candidate agents which modulate neuropsychiatric disorders or neuropsychiatric disorder susceptibility. Methods and reagents for the diagnosis and treatment of neuropsychiatric disorders. Methods for the diagnosis of neuropsychiatric disorders and susceptibility to neuropsychiatric disorders by detecting polymorphisms, mutations, variations, alterations in expression, and the like, in neuropsychiatric disorder-related genes, or polymorphisms linked to these genes. Compositions and methods for treating neuropsychiatric disorders or neuropsychiatric disorder susceptibility. Pharmaceutical compositions for treating a neuropsychiatric disorder or neuropsychiatric disorder susceptibility are provided.
    • 鉴定参与神经精神障碍(例如双相和相关病症)的核酸和基因表达谱,以及这些表达谱和核酸在鉴定调节神经精神障碍或神经精神障碍易感性的候选药物的方法中的用途。 用于诊断和治疗神经精神障碍的方法和试剂。 通过检测神经精神障碍相关基因中的多态性,突变,变异,表达变化等,或与这些基因相关的多态性来诊断神经精神障碍和对神经精神障碍的敏感性的方法。 用于治疗神经精神障碍或神经精神障碍易感性的组合物和方法。 提供了用于治疗神经精神障碍或神经精神障碍易感性的药物组合物。